Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab

University of California, San Francisco · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
recurrent plasma cell myeloma, refractory plasma cell myeloma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 918125
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.